Page 13 - Pharmaceutical Firms
Biocon looks to derive sales from US, EU to break even at Malaysia unit
According to an Edelweiss report, investments would pick up at the company subsidiary in the current financial year
 "Biocon looks to derive sales from US, EU to break even at Malaysia unit")
From auto to banking, grumble of slowdown is getting louder for India Inc
The companies' combined net profit declined by 10.1 per cent yoy during June '19 quarter against 26.2 per cent yoy growth a year ago
 "From auto to banking, grumble of slowdown is getting louder for India Inc")
Wockhardt consolidated net loss narrows to Rs 45 cr for June 2019 quarter
Total income of the company stood at Rs 871.19 crore during the quarter under review
 "Wockhardt consolidated net loss narrows to Rs 45 cr for June 2019 quarter")
As price pressure mounts, pharma companies tap analytics to cut costs
Cipla is the first company in the Asia Pacific to upgrade to a cloud-based pharmacovigilance solution
 "As price pressure mounts, pharma companies tap analytics to cut costs")
India's new drug nods from US dip in Q1 due to increased scrutiny on firms
India's share of ANDA approvals given by the US Food and Drug Administration (USFDA), too, has fallen from 43 per cent in fourth quarter (Q4) of 2018-19 (FY19) to 33 per cent in Q1FY20
 "India's new drug nods from US dip in Q1 due to increased scrutiny on firms")
Growth in US business likely to boost Q1 revenues of pharma companies
According to Edelweiss Securities, pharma sales to grow by 17 per cent YoY as US sales are expected to grow by 21 per cent YoY
 "Growth in US business likely to boost Q1 revenues of pharma companies")
It's time for India's one-brand pharma firms to scale up, diversify
Many of these brands are not protected against the discovery a new, more efficient molecule as the small firms that own them have not kept pace with the latest research
 "It's time for India's one-brand pharma firms to scale up, diversify")
